A phase I/II pharmacokinetic and safety study of T-20 [enfuvirtide] in combination with an optimized background in HIV infected children and adolescents.
Phase of Trial: Phase I/II
Latest Information Update: 18 Feb 2016
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Roche
- 11 Oct 2005 New trial record.